| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |